Product Description:
Product Name: Bictegravir CAS NO:1611493-60-7
Synonyms:
(2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide;
GS-9883;
Chemical & Physical Properties:
Appearance: White crystalline powder
Assay :≥99.0%
Density:1.62g/cm3
Boiling Point: 682.5℃ at 760 mmHg
Flash Point:366.6℃
Biquetegravir (BIC) is a second-generation integrase chain transfer inhibitor (INSTI). It has been approved for use in HIV treatment in combination with emtricitabine and tenofovir alafenamide in fixed doses. The first-generation resistant strains have effective antiviral activity INSTIs in vitro.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.